AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26932146
Drug: DMF 240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DMF 240 mg BID
Trial: 27207449
Drug: DMF 240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DMF 240 mg TID
Trial: 24345717
Drug: Venlafaxine extended
RxNorm normalized name: Desvenlafaxine Extended-Release Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine extended release (ER) (75-300 mg/d)
Trial: 21537042
Drug: Goserelin (3.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goserelin (3.6 mg subcutaneously every 4 weeks until the end of the last cycle)
Trial: 21537042
Drug: Chemotherapy alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy alone (anthracycline/cyclophosphamide with or without taxane)
Trial: 14756851
Drug: Diclofenac softgel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac softgel 100 mg
Trial: 14756851
Drug: Diclofenac softgel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac softgel 100 mg plus caffeine 100 mg
Trial: 10030097
Drug: Classical pharmacological
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Classical pharmacological treatments (diuretics and beta blockers)
Trial: 10030097
Drug: New drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New drugs (calcium antagonists and angiotensin converting enzyme inhibitors)
Trial: 10030097
Drug: Non pharmacological
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non pharmacological therapies (sodium restriction, weight reduction, avoidance of alcohol intake, calcium and potassium supplementation)
Trial: 8047525
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine system 7 mg per day
Trial: 8047525
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine system 14 mg per day
Trial: 8047525
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine system 21 mg per day
Trial: 31311361
Drug: Control medication
RxNorm normalized name: zinc pyrithione Medicated Shampoo [Dial Dandruff Control]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control medication at baseline
Trial: 11057350
Drug: Emedastine 0.05%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emedastine 0.05% ophthalmic solution BID
Trial: 11057350
Drug: Levocabastine 0.05%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levocabastine 0.05% ophthalmic suspension BID
Trial: 31784483
Drug: Drug effect
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug effect of -0.5 points in MDS-UPDRS per year
Trial: 27622699
Drug: Fluticasone Furoate
RxNorm normalized name: Fluticasone Furoate
DrugBank: Fluticasone furoate (DB08906)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluticasone Furoate (FF) 25 µg once daily
Trial: 27622699
Drug: Fluticasone Furoate
RxNorm normalized name: Fluticasone Furoate
DrugBank: Fluticasone furoate (DB08906)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluticasone Furoate (FF) 50 µg once daily
Trial: 27622699
Drug: Fluticasone Furoate
RxNorm normalized name: Fluticasone Furoate
DrugBank: Fluticasone furoate (DB08906)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluticasone Furoate (FF) 100 µg once daily
Trial: 27622699
Drug: Fluticasone Propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone Propionate (FP) 100 µg twice daily
Trial: 23739219
Drug: Misoprostol 400
RxNorm normalized name: Misoprostol 400 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misoprostol 400 µg vaginally 4 hours prior to IUD insertion
Trial: 14660300
Drug: Epoetin-alpha (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epoetin-alpha (150 U/kg or 250 U/kg, thrice weekly for 12 weeks)
Trial: 25519197
Drug: High-dose probiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose probiotics (10^10 cells for 21 days)
Trial: 25519197
Drug: Standard-dose probiotics
RxNorm normalized name: PROBIOTIC
DrugBank: Bifidobacterium longum (DB19248)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose probiotics (10^10 cells for 14 days)
Trial: 25519197
Drug: Lower-dose probiotics
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower-dose probiotics (10^9 cells for 21 days)
Trial: 24378016
Drug: 4g/day prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4g/day prescription omega‐3 fatty acid ethyl ester (P‐OM3)
Trial: 24378016
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (P‐OM3 + ERN)
Trial: 10711900
Drug: Topical aqueous
RxNorm normalized name: Pen-Aqueous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical aqueous suppressants
Trial: 10711900
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no topical aqueous suppressants)
Trial: 7661062
Drug: Aspirin 300
RxNorm normalized name: aspirin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 300 mg loading dose
Trial: 7661062
Drug: Aspirin 500
RxNorm normalized name: aspirin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 500 mg loading dose
Trial: 7661062
Drug: Aspirin 100
RxNorm normalized name: aspirin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 100 mg loading dose
Trial: 7661062
Drug: Aspirin 40/40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 40/40 mg combination
Trial: 7661062
Drug: Different combinations
RxNorm normalized name: combinations of different antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Different combinations of aspirin doses
Trial: 2194770
Drug: Midazolam (0.1-0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.1-0.15 mg/kg)
Trial: 2194770
Drug: Diazepam (0.2-0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (0.2-0.4 mg/kg)
Trial: 498700
Drug: Intravenous verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous verapamil
Trial: 31793991
Drug: Presatovir 200
RxNorm normalized name: Presatovir
DrugBank: Presatovir (DB12165)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Presatovir 200 mg
Trial: 31793991
Drug: Presatovir 200
RxNorm normalized name: Presatovir
DrugBank: Presatovir (DB12165)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Presatovir 200 mg (in lymphopenic patients)
Trial: 23993706
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone (0.5 mg/kg BW daily) for 2 weeks
Trial: 22290033
Drug: Drug therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug therapy (fluoxetine)
Trial: 22290033
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of CBT and fluoxetine (CBT+fluoxetine)
Trial: 15311169
Drug: Lower doses
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower doses of beta-blockers
Trial: 11323149
Drug: 125 mg
RxNorm normalized name: niacin 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 125 mg codeine
Trial: 8225629
Drug: 1% clindamycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% clindamycin hydrochloride gel
Trial: 2952095
Drug: Amantadine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amantadine (300 mg/day, t.i.d.)
Trial: 28095573
Drug: SB204 2%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SB204 2% twice daily
Trial: 28095573
Drug: SB204 4%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SB204 4% once daily
Trial: 28095573
Drug: SB204 4%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SB204 4% twice daily
Trial: 17846933
Drug: Movina (St
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Movina (St John's Wort product, 300 mg Hypericum perforatum, two tablets daily)
Trial: 17846933
Drug: Control (commercially
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (commercially available multivitamin tablet, Vitamineral)
Trial: 15151614
Drug: LAT (lansoprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LAT (lansoprazole 30 mg b.d., amoxycillin 1000 mg b.d., tinidazole 500 mg b.d.)
Trial: 15151614
Drug: LAC (lansoprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LAC (lansoprazole 30 mg b.d., amoxycillin 1000 mg b.d., clarithromycin 500 mg b.d.)
Trial: 9841945
Drug: Cotton pledge
RxNorm normalized name: Cotton
DrugBank: Cotton (DB10707)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cotton pledge soaked in 5% cocaine solution (middle nasal meatus stimulation)
Trial: 7986255
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg cyclandelate
Trial: 31942818
Drug: Hand-Arm Bimanual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hand-Arm Bimanual Intensive Therapy (HABIT)
Trial: 27611301
Drug: rTMS treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rTMS treatment (10 sessions over the bilateral dorsolateral prefrontal cortex)
Trial: 26463489
Drug: Moxifloxacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxifloxacin (400 mg qd)
Trial: 9404904
Drug: Levofloxacin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin (500 mg qd)
Trial: 9794155
Drug: Mono‐Tildiem LP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mono‐Tildiem LP 300 (300 mg)
Trial: 9794155
Drug: Adizem XL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adizem XL (300 mg)
Trial: 9794155
Drug: Cardizem (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardizem (300 mg)
Trial: 9794155
Drug: Dilacor (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dilacor (240 mg)
Trial: 8605713
Drug: 14 gauge
RxNorm normalized name: intravenous catheter 14 gauge X 2" MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14 gauge needles at QB 500 cc/min
Trial: 8605713
Drug: 17 gauge
RxNorm normalized name: lancets 17 gauge MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17 gauge needles at QB 500 cc/min
Trial: 8605713
Drug: 14 gauge
RxNorm normalized name: intravenous catheter 14 gauge X 2" MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14 gauge needles at QB 200 cc/min
Trial: 8605713
Drug: 17 gauge
RxNorm normalized name: lancets 17 gauge MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17 gauge needles at QB 200 cc/min
Trial: 31583805
Drug: Responsive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Responsive treatment
Trial: 20495139
Drug: Phenylephrine 100
RxNorm normalized name: phenylephrine 100 mcg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenylephrine 100 μg/min
Trial: 28235526
Drug: Ephedrine 5
RxNorm normalized name: pseudoephedrine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ephedrine 5 mg/min
Trial: 26032587
Drug: Dihydromyricetin (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydromyricetin (150 mg, two capsules twice daily for three months)
Trial: 26032587
Drug: Placebo (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (150 mg, two capsules twice daily for three months)
Trial: 21462332
Drug: Isolated coumarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isolated coumarin in a capsule (reference)
Trial: 21462332
Drug: Cinnamon in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinnamon in capsules
Trial: 18707693
Drug: Duloxetine (switch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine (switch method: direct switch or start-taper switch)
Trial: 18707693
Drug: Duloxetine (start-taper
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine (start-taper switch)
Trial: 18707693
Drug: Duloxetine (overall
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine (overall treatment)
Trial: 15147430
Drug: SRL‐ST (sirolimus-steroid)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRL‐ST (sirolimus-steroid)
Trial: 28784701
Drug: Lactobacillus rhamnosus
RxNorm normalized name: Lactobacillus Rhamnosus
DrugBank: Lacticaseibacillus rhamnosus (DB19282)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus rhamnosus GG (LGG) supplementation (10 billion CFU and 225 mg of inulin)
Trial: 28784701
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (325 mg of inulin alone)
Trial: 20386003
Drug: Enhanced depression
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enhanced depression treatment
Trial: 10943869
Drug: 20 mg/day
RxNorm normalized name: futibatinib 20 mg/day (4 mg x 5) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/day intravenous administration of anti‐IL‐10 monoclonal antibody (B‐N10) for 21 consecutive days
Trial: 9077368
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment (7 sessions during weeks 10 and 11)
Trial: 3944815
Drug: Atropine 1.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine 1.8 mg
Trial: 3944815
Drug: Glycopyrrolate 0.6
RxNorm normalized name: glycopyrrolate 0.6 MG in 3 mL Prefilled Syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycopyrrolate 0.6 mg
Trial: 3944815
Drug: Glycopyrrolate 0.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycopyrrolate 0.9 mg
Trial: 29798500
Drug: Sublingual immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual immunotherapy (SLIT) with standardized dermatophagoides farinae drops for 12 months
Trial: 27348641
Drug: Arnica ointment
RxNorm normalized name: Arnica Ointment
DrugBank: Arnica montana flower (DB14343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arnica ointment 10%
Trial: 18674411
Drug: Rivastigmine capsules
RxNorm normalized name: Rivastigmine
DrugBank: Rivastigmine (DB00989)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Rivastigmine capsules (3-12 mg/day) in older patients (>=75 years old)
Trial: 18674411
Drug: Rivastigmine capsules
RxNorm normalized name: Rivastigmine
DrugBank: Rivastigmine (DB00989)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Rivastigmine capsules (3-12 mg/day) in younger patients (less than 75 years old)
Trial: 18674411
Drug: Rivastigmine capsules
RxNorm normalized name: Rivastigmine
DrugBank: Rivastigmine (DB00989)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Rivastigmine capsules (3-12 mg/day) in patients with medial temporal atrophy
Trial: 1510255
Drug: 0.15 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.15 mg/kg of metoclopramide
Trial: 31347692
Drug: Fe‐Gly (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fe‐Gly (60 mg Fe/kg)
Trial: 31347692
Drug: Fe‐Gly (60,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fe‐Gly (60, 80 mg Fe/kg)
Trial: 31347692
Drug: Fe‐Gly (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fe‐Gly (40 mg Fe/kg)
Trial: 30693979
Drug: FeSO4 (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FeSO4 (60 mg Fe/kg)
Trial: 27456147
Drug: Tunneled subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tunneled subcutaneous perineural catheter
Trial: 7791603
Drug: Cover stories
RxNorm normalized name: Canker Cover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cover stories involving different pairs of element sets (e.g., objects and people)
Trial: 7791603
Drug: Cover stories
RxNorm normalized name: Canker Cover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cover stories involving similar sets of people (e.g., doctors and doctors)
Trial: 1787651
Drug: 4% branched-chain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% branched-chain amino acid (BCAA) solution
Trial: 31564503
Drug: MID‐O2 (midazolam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MID‐O2 (midazolam 1 mg kg‐1 IM)
Trial: 19947365
Drug: Combined use
RxNorm normalized name: CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined use of the virus vaccine and chemotherapy (group A)
Trial: 19947365
Drug: Therapy with
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapy with the vaccine alone (group B)
Trial: 19947365
Drug: Chemotherapy regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy regimen identical with that used in group A (group C)
Trial: 17456483
Drug: Trimetazidine (TMZ)
RxNorm normalized name: trimetazidine
DrugBank: Trimetazidine (DB09069)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimetazidine (TMZ) 20 mg tid for 4 weeks
Trial: 12953348
Drug: Aprepitant 125
RxNorm normalized name: aprepitant 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aprepitant 125 mg coadministered with digoxin on Day 7
Trial: 12953348
Drug: Aprepitant 80
RxNorm normalized name: aprepitant 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aprepitant 80 mg coadministered with digoxin on Days 8 to 11
Trial: 8682031
Drug: Flecainide 100
RxNorm normalized name: flecainide 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flecainide 100 mg for paroxysmal supraventricular tachycardia
Trial: 8682031
Drug: Flecainide 200
RxNorm normalized name: flecainide 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flecainide 200 mg for paroxysmal atrial fibrillation
Trial: 8682031
Drug: Propafenone 450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone 450 mg for paroxysmal supraventricular tachycardia
Trial: 8682031
Drug: Propafenone 450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone 450 mg for paroxysmal atrial fibrillation
Trial: 30680980
Drug: Alkalinized 2%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alkalinized 2% lidocaine (group L)
Trial: 15383189
Drug: Budesonide/formoterol single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/formoterol single inhaler therapy (160/4.5 microg, 2 inhalations once daily)
Trial: 15383189
Drug: Budesonide/formoterol single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/formoterol single inhaler therapy
Trial: 15383189
Drug: Budesonide (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (160 microg, 2 inhalations twice daily) plus terbutaline 0.4 mg as needed
Trial: 11480224
Drug: Diazepam 15
RxNorm normalized name: diazepam 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 15 mg intravenously (gr. 1)
Trial: 11480224
Drug: Diazepam 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 30 mg orally (gr. 2)
Trial: 31656294
Drug: Single-injection intraarticular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-injection intraarticular anesthesia
Trial: 25517501
Drug: Bundle therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bundle therapy (Tracheostomy followed by ventilator-Assisted breathing with reverse trendelenburg position, early goal-directed hemodynamic support, enteral nutrition by nasointestinal tube, effective antibiotic usage and large doses of expectorants)
Trial: 25517501
Drug: Bundle therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bundle therapy
Trial: 17897912
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no PE treatment)
Trial: 9797798
Drug: Single subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single subcutaneous doses of epoetin alfa (300, 450, 600, 900, 1200, 1350, 1800, and 2400 IU/kg)
Trial: 9797798
Drug: Multiple subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple subcutaneous doses of epoetin alfa (150 IU/kg 3 times a week for 4 weeks)
Trial: 9797798
Drug: Multiple subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple subcutaneous doses of epoetin alfa (600 IU/kg once per week for 4 weeks)
Trial: 9797798
Drug: Single-dose regimens
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose regimens of epoetin alfa
Trial: 636501
Drug: No antimicrobial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antimicrobial chemotherapy
Trial: 23248028
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of mycophenolate mofetil (MMF) and pulse dexamethasone (DEX)
Trial: 19076110
Drug: Bupivacaine 2.5
RxNorm normalized name: Sure-Amp BUPivacaine 2.5 MG/ML Injectable Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 2.5 mg/ml, 1 ml/kg with DEX 1 microg/kg
Trial: 19076110
Drug: Bupivacaine 2.5
RxNorm normalized name: Sure-Amp BUPivacaine 2.5 MG/ML Injectable Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 2.5 mg/ml, 1 ml/kg
Trial: 15051744
Drug: Azimilide dihydrochloride
RxNorm normalized name: Levocetirizine Dihydrochloride
DrugBank: Azimilide (DB04957)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azimilide dihydrochloride 125 mg every 12 hours for 3 days, then every 24 hours for 5 days
Trial: 15051744
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg coadministered on Day 8
Trial: 11605290
Drug: Extracorporal shock
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporal shock wave therapy (ESWT)